Exotic and emerging viral encephalitides

Current Opinion in Neurology

Volumn 16, Issue 3, 2003, Pages 411-418

  Solomon, Tom ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Dengue; Enterovirus 71; Japanese encephalitis; Nipah virus; West Nile encephalitis

Indexed keywords

ALPHA INTERFERON; ENCEPHALITIS VACCINE; IMMUNOGLOBULIN; RECOMBINANT ALPHA2A INTERFERON; RIBAVIRIN;

CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; ENCEPHALITIS; ENTEROVIRUS 71; EPIDEMIC ENCEPHALITIS; EPIDEMIOLOGICAL DATA; FLACCID PARALYSIS; FOOT AND MOUTH DISEASE; HUMAN; MALAYSIA; NEUROLOGIC EXAMINATION; NIPAH VIRUS; PATHOGENESIS; REVIEW; TROPICS; VACCINE PRODUCTION; VIRUS CELL INTERACTION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

ANIMALS; ARBOVIRUS INFECTIONS; ASIA; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; ENCEPHALITIS, VIRAL; HUMANS; INTERFERON-ALPHA; PARAMYXOVIRINAE; VACCINES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 0038458968     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200306000-00023     Document Type: Review

References (78)

1. Solomon T, Cardosa MJ. Emerging arboviral encephalitis. BMJ 2000; 321:1484-1485.
2. Solomon T, Ooi MH, Beasley DWC, Mallewa MJ. Clinical review: West Nile encephalitis. BMJ (in press).
3. Centers for Disease Control and Prevention. West Nile virus update - current case count. http://www.cdc.gov/od/oc/media/wncount.htm. [Accessed 31 December 2002.]
4. West Nile virus infection in organ donor and transplant recipients - Georgia and Florida, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:790.
5. Solomon T, Fisher AF, Beasley DWC, et al. Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders. Clin Infect Dis (in press).
6. Possible West Nile virus transmission to an infant through breast-feeding - Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:877-878.
7. Provisional surveillance summary of the West Nile virus epidemic - United States, January-November 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1129-1133.
8. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001; 344:1807-1814.
9. Asnis DS, Conetta R, Teixeira AA, et al. The West Nile virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis 2000; 30:413-418.
10. Klein C, Kimiagar I, Pollak L, et al. Neurological features of West Nile Virus infection during the 2000 outbreak in a regional hospital in Israel. J Neurol Sci 2002; 200:63-66.
11. Solomon T, Vaughn DW. Clinical features and pathophysiology of Japanese encephalitis and West Nile virus infections. In: Deubel V, editor. Current topics in microbiology and immunology: Japanese encephalitis and West Nile virus infections. Berlin: Springer; 2002. pp. 171-194.
12. Leis AA, Stokic DS, Polk JL, et al. A poliomyelitis-like syndrome from West Nile virus infection. N Engl J Med 2002; 347:1279-1280. Useful reminder that West Nile virus, along with most flaviviruses, can cause a polio-like flaccid paralysis in fully conscious patients.
13. Newman W, Southam CM. Virus treatment in advanced cancer: a pathological study of fifty-seven cases. Cancer 1954; 7:106-118.
14. Leis AA, Fratkin J, Stokic DS, et al. West Nile poliomyelitis. Lancet Infect Dis 2003; 3:9-10.
15. Gadoth N, Weitzman S, Lehmann EE. Acute anterior myelitis complicating West Nile fever. Arch Neurol 1979; 36:172-173.
16. World Health Organization. Acute onset flaccid paralysis. Geneva: WHO; 1993.
17. Amor S. Virus infections of the central nervous system. In: Cook G, Zumlar A, editors. Manson's tropical diseases. London: Saunders; 2002. pp. 861-890.
18. Anderson JF, Rahal JJ. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 2002; 8:107-108.
19. Rahat J, Anderson J, Rosenberg C, et al. Effect of interferon alpha-2b on St. Louis (SL) virus meningoencephalitis: clinical and laboratory results. Infectious Diseases Society of America, 40th Meeting; Chicago, Illinois; 2002. p. 823.
20. Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 2001; 7:675-678.
21. Hamdan A, Green P, Mendelson E, et al. Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis. Transpl Infect Dis 2002; 4:160-162.
22. Shimoni Z, Niven MJ, Pitlick S, Bulvik S. Treatment of West Nile virus encephalitis with intravenous immunoglobulin. Emerg Infect Dis 2001; 7:759.
23. Tesh RB, Travassos Da Rosa AP, Guzman H, et al. Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis. Emerg Infect Dis 2002; 8:245-251. This study in hamsters implies that even though there is no vaccine available yet against West Nile virus, vaccines against related flaviviruses might offer some protection.
24. Kanesa-Thasan N, Putnak JR, Mangiafico JA, et al. Short report: absence of protective neutralizing antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines. Am J Trop Med Hyg 2002; 66:115-116.
25. Lanciotti RS, Ebel GD, Deubel V, et al. Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 2002; 298:96-105.
26. Beasley DWC, Davis CT, Guzman H, et al. Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States. Virology (in press).
27. Burt FJ, Grobbelaar AA, Leman PA, et al. Phylogenetic relationships of southern African West Nile virus isolates. Emerg Infect Dis 2002; 8:820-826.
28. Beasley DW, Li L, Suderman MT, Barrett AD. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 2002; 296:17-23.
29. Mashimo T, Lucas M, Simon-Ohazottes D, et al. A nonsense mutation in the gene encoding 2′-5′-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci U S A 2002; 99:11311-11316. A genetic locus determining susceptibility/resistance to West Nile virus infection in mice was mapped to chromosome 5, where a cluster of genes encoding a family of IFN-inducible proteins (2′-5′-oligoadenylate synthetases) was found to be the most prominent candidate. Nucleic acid sequence comparison of the three isoforms of the gene showed a mutation causing a stop codon and thus a truncated protein was associated with susceptibility. The implication is that, in animal models at least, a point mutation in a single gene may determine host susceptibility to West Nile virus infection.
30. Dash AP, Chhotray GP, Mahapatra N, Hazra RK. Retrospective analysis of epidemiological investigation of Japanese encephalitis outbreak occurred in Rourkela, Orissa, India. Southeast Asian J Trop Med Public Health 2001; 32:137-139.
31. Chhour YM, Ruble G, Hong R, et al. Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian children. Emerg Infect Dis 2002; 8:485-489.
32. Libraty DH, Nisalak A, Endy TP, et al. Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans R Soc Trop Med Hyg 2002; 96:173-178.
33. Harinasuta C, Wasi C, Vithanomsat S. The effect of interferon on Japanese encephalitis virus in vitro. 1984; 15:564-568.
34. Liu J-L. Protective effect of interferon alpha on mice experimentally infected with Japanese encephalitis virus. Chinese J Microbiol 1972; 5:1-9.
35. Harinasuta C, Nimmannitya S, Titsyakorn U, et al. A clinical trial of interferon-alpha on Japanese encephalitis in Thailand [abstract]. Southeast Asian J Trop Med Public Health 1989; 20:656-657.
36. Harinasuta C, Nimmanitya S, Titsyakorn U. The effect of interferon alpha on two cases of Japanese encephalitis in Thailand. SE Asian J Trop Med Pub Health 1985; 16:332-336.
37. Solomon T, Dung NM, Wills B, et al. Interferon alpha-2a in Japanese encephalitis: a double-blind placebo controlled trial. Lancet; 361:831-836. This study, the first randomised double-blind trial of an antiviral treatment for any flavivirus infection, showed interferon α did not improve the outcome in Japanese encephalitis.
38. Kumar R, Mathur A, Kumar A, et al. Clinical features and prognostic indicators of Japanese encephalitis in children in Lucknow (India). Indian J Med Res 1990; 91:321-327.
39. Solomon T, Dung NM, Kneen R, et al. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain 2002; 125 (Pt 5):1084-1093.
40. Misra UK, Kalita J. Seizures in Japanese encephalitis. J Neurol Sci 2001; 190:57-60.
41. Hoke CH, Nisalak A, Sangawhipa N, et al. Protection against Japanese encephalitis by inactivated vaccines. New Engl J Med 1988; 319:608-614.
42. Shlim DR, Solomon T. Japanese encephalitis vaccine for travelers: exploring the limits of risk. Clin Infect Dis 2002; 35:183-188.
43. Hennessy S, Zhengle L, Tsai TF, et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case control study. Lancet 1996; 347:1583-1586.
44. Monath TP, Soike K, Levenbook I, et al. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Vaccine 1999; 17:1869-1882.
45. Monath TP, McCarthy K, Bedford P, et al. Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. Vaccine 2002; 20:1004-1018. This randomised, double-blind, study in 12 human volunteers showed a chimeric Japanese encephalitis/17D yellow fever vaccine was safe and immunogenic, and marks an important step in the vaccine's development.
46. Chen WR, Tesh RB, Ricco-Hesse R. Genetic variation of Japanese encephalitis virus in nature. J Gen Virol 1990; 71:2915-2922.
47. Holbrook M, Barrett AD. Molecular epidemiology of Japanese encephalitis virus. In: Mackenzie JS, Barrett AD, Deubel V, editors. Current topics in microbiology and immunology: Japanese encephalitis and West Nile virus infections: Berlin: Springer; 2002. pp. 75-90.
48. Gould EA. Evolution of the Japanese serological group viruses. In: Mackenzie JS, Barrett AD, Deubel V, editors. Current topics in microbiology and immunology: Japanese encephalitis and West Nile virus infections: Berlin: Springer; 2002. pp. 391-404.
49. Solomon T, Ni H, Beasley DWC, et al. The origin and evolution of Japanese encephalitis virus in Southeast Asia. J Virol; 77:3091-3098. A detailed molecular phylogenetic analysis suggested that Japanese encephalitis virus originated in the Indonesia-Malaysia region, and evolved into the different genotypes, which then spread from here.
50. Lee E, Lobigs M. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray valley encephalitis virus. J Virol 2002; 76:4901-4911. An elegant study relating biological changes in the virus' binding to cell surface glycosaminoglycans, and attenuation in mouse neurovirulence to amino acid changes in the receptor binding domain of the virus' envelope protein.
51. Yamamoto Y, Takasaki T, Yamada K, et al. Acute disseminated encephalomyelitis following dengue fever. J Infect Chemother 2002; 8:175-177.
52. Pancharoen C, Thisyakorn U. Neurological manifestations in dengue patients. Southeast Asian J Trop Med Public Health 2001; 32:341-345.
53. Cam BV, Fonsmark L, Hue NB, et al. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am J Trop Med Hyg 2001; 65:848-851.
54. Brown JL, Wilkinson R, Davidson RN, et al. Rapid diagnosis and determination of duration of viraemia in dengue fever using a reverse transcriptase polymerase chain reaction. Trans R Soc Trop Med Hyg 1996; 90:140-143.
55. Mangiafico JA, Rossi CA, Ludwig GV. Short report: isolation and identification of Venezuelan equine encephalitis virus from a human in Panama. Am J Trop Med Hyg 2002; 67:112-113.
56. Chua KB, Goh KJ, Wong KT, et al. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet 1999; 354:1257-1259.
57. Chong HT, Kunjapan SR, Thayaparan T, et al. Nipah encephalitis outbreak in Malaysia, clinical features in patients from Seremban. Can J Neurol Sci 2002; 29:83-87.
58. Chua KB, Koh CL, Hooi PS, et al. Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect 2002; 4:145-151. Elucidating the natural history of this new virus may be an important step towards avoiding future outbreaks.
59. Wong SC, Ooi MH, Wong MN, et al. Late presentation of Nipah virus encephalitis and kinetics of the humoral immune response. J Neurol Neurosurg Psychiatry 2001; 71:552-554.
60. Tan CT, Goh KJ, Wong KT, et al. Relapsed and late-onset Nipah encephalitis. Ann Neurol 2002; 51:703-708.
61. Lim CC, Lee WL, Leo YS, et al. Late clinical and magnetic resonance imaging follow up of Nipah virus infection. J Neurol Neurosurg Psychiatry 2003; 74:131-133.
62. Rodriguez JJ, Parisien JP, Horvath CM. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol 2002; 76:11476-11483.
63. McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 2002; 26:91-107.
64. Cardosa MJ, Krishnan S, Tio PH, et al. Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak. Lancet 1999; 354:987-991.
65. Chan LG, Parashar UD, Lye MS, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Ciin Infect Dis 2000; 31:876-683.
66. Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 1 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 1999; 341:929-935.
67. Lum LC, Wong KT, Lam SK, et al. Fatal enterovirus 71 encephalomyelitis. J Pediatr 1998; 133:795-798.
68. Huang CC, Liu CC, Chang YC, et al. Neurologic complications in children with enterovirus 71 infection. New Engl J Med 1999; 341:936-942.
69. Wang SM, Liu CC, Tseng HW, et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis 1999; 29:184-190.
70. Chang LY, Lin TY, Hsu KH, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 1999; 354:1682-1686.
71. Lin TY, Chang LY, Hsia SH, et al. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis 2002; 34 (Suppl 2):S52-S57.
72. Huang FL, Jan SL, Chen PY, et al. Left ventricular dysfunction in children with fulminant enterovirus 71 infection: an evaluation of the clinical course. Clin Infect Dis 2002; 34:1020-1024.
73. Yan JJ, Wang JR, Liu CC, et al. An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J Clin Virol 2000; 17:13-22.
74. Wu JM, Wang JN, Tsai YC, et al. Cardiopulmonary manifestations of fulminant enterovirus 71 infection. Pediatrics 2002; 109:E26. This detailed haemodynamic study marks the way forward for resolving controversies such as the cause of pulmonary oedema in enterovirus 71 infection. In the patients studied there was little to suggest increased hydrostatic pressure in the pulmonary vasculature.
75. McMinn P, Lindsay K, Perera D, et al. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol 2001; 75:7732-7738.
76. Wang JR, Tuan YC, Tsai HP, et al. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol 2002; 40:10-15.
77. Lum LC, Chua KB, McMinn PC, et al. Echovirus 7 associated encephalomyelitis. J Clin Virol 2002; 23:153-160.
78. Ooi MH, Wong SC, Clear D, et al. Adenovirus-21 associated acute flaccid paralysis during a hand foot and mouth disease outbreak in Sarawak, Malaysia. Clin Infect Dis; 36:550-559.